NCT03242655
- Conditions
- Blood-Borne Infections, Chemically-Induced Disorders, Communicable Diseases, +12 more
- Locations
-
- Comprehensive Health Care Center The Bronx, New York, United States
Clinical trial condition
Liver Diseases
Explore clinical trials studying Liver Diseases. Study availability and eligibility vary by location and protocol.
8,392 public trials
1,305 recruiting studies
Liver Diseases trial results
NCT02832882
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
- Locations
-
Not specified
NCT02072746
- Conditions
- Alcohol-Induced Disorders, Alcohol-Related Disorders, Alcoholic Cirrhosis, +10 more
- Locations
-
- University of Louisville Louisville, Kentucky, United States
NCT03839979
- Conditions
- Blood-Borne Infections, Cardiovascular Diseases, Communicable Diseases, +18 more
- Locations
-
- Egyptian Ministry of Health Asyut, Egypt
NCT02548910
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Hepatectomy, +4 more
- Locations
-
- The Ottawa Hospital - General Campus Ottawa, Ontario, Canada
Completed
Holmium Radioembolization as Adjuvant Treatment to RFA for Early Stage HCC: Dose Finding Study
NCT03437382
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
- Leiden University Medical Center Leiden, South Holland, Netherlands
NCT02144597
- Conditions
- Body Weight, Digestive System Diseases, Fatty Liver, +11 more
- Locations
-
- Imperial Clinical research facility London, Greater London, United Kingdom
Completed
A First in Human Study to Evaluate the Safety, Tolerability and PK of GB1211 in Healthy Subjects
NCT03809052
- Conditions
- Digestive System Diseases, Fatty Liver, Fibrosis, +6 more
- Locations
-
- (For Parts A and B) Covance Clinical Research Unit Ltd Leeds, United Kingdom
NCT03312036
- Conditions
- Acute-On-Chronic Liver Failure, Digestive System Diseases, Hepatic Insufficiency, +4 more
- Locations
-
- Nephrology Dialysis and Renal Transplantation Unit, S.Orsola University Hospital Bologna, Italy
Completed
Drug Interaction Potential Between Dolutegravir and Simeprevir in HIV/HCV Seronegative Volunteers
NCT02404805
- Conditions
- Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
- Locations
-
- University of Colorado Anschutz Medical Campus Aurora, Colorado, United States